NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
April 5, 2005 • Volume 2 / Number 14 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Adoptive Cell Transfer Shows Dramatic Results in Refractory Melanoma

Director's Update
The Global Impact of 2015

Spotlight
Novel Aspirin Offers Promise for Colorectal Cancer Prevention

Cancer Research Highlights
Kidney Cancer Drug Delays Disease Progression

Collagen VII Mutation Linked to Skin Cancer's Spread

Immunosuppressive Drug Sirolimus Can Inhibit Kaposi's Sarcoma in Kidney Transplant Patients

Rapamycin Agent Improves Response to Low-Dose Cisplatin

Colorectal Screening for African Americans Should Start at Age 45, Panel Urges

Funding Opportunities

Featured Clinical Trial
Oblimersen Treatment for Older Patients with AML

Notes
Fourth International Conference on Cervical Cancer

CTWG Seeks Feedback on Draft Recommendations

caBIG Annual Meeting will be Webcast Live

Science Writers' Seminar on Childhood Cancers

CCR Grand Rounds

Community Update
"Toward the Last Cohort"

Bulletin Archive

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Notes

CCR Grand Rounds
April 12: Dr. Bruce E. Johnson, Director, Lowe Center for Thoracic Oncology Dana-Farber Cancer Institute, Associate Professor of Medicine, Harvard Medical School. "Impact of EGFR Mutations on the Treatment of Lung Cancer"

April 19: No lecture. American Association of Cancer Research (AACR) meeting April 16-20, Anaheim, Calif.

April 26: Dr. John T. Schiller, Senior Investigator, Laboratory of Cellular Oncology, Center for Cancer Research, NCI. "Recent Advances in Prophylactic HPV/Cervical Cancer Vaccines"

Fourth International Conference on Cervical Cancer
The University of Texas M. D. Anderson Cancer Center will sponsor and host the Fourth International Conference on Cervical Cancer, May 19-22, 2005, in Houston, Texas. The conference will be co-sponsored by the Johns Hopkins University School of Medicine, NCI, the Centers for Disease Control and Prevention, the European Institute of Oncology, Medical School of the University of Turin, and the Mirano Medical Center (Venice, Italy). The conference goal is to provide an update on research in cervical cancer by assembling leaders from multiple disciplines involved with all aspects of cervical cancer causation, prevention, and screening. The conference will focus on optical techniques for screening and detection, novel surgical approaches and chemo-radiation, prophylactic and therapeutic HPV vaccines, behavioral interventions, and quality-of-life issues. For more information go to http://www.mdanderson.org.

CTWG Seeks Feedback on Draft Recommendations
NCI's Clinical Trials Working Group (CTWG) is requesting feedback on its draft recommendations to improve the national clinical trials system. Developed over the last few months, the draft recommendations evaluate the strengths and weaknesses of the current system and address a wide range of issues. They are posted on the CTWG Web site (http://integratedtrials.nci.nih.gov). All stakeholders in the clinical trials process are encouraged to submit feedback to ctwgfeedback@mail.nih.gov by April 15. Comments will be considered during the preparation of the final recommendations, which will be presented to the National Cancer Advisory Board at its June 7 meeting.

caBIG Annual Meeting will be Webcast Live
The plenary sessions of the 2005 caBIG Annual Meeting on April 12-13 will be webcast live. Due to a large response, registration to attend the meeting has already been closed. The webcast will enable additional interested individuals to learn about the latest developments in NCI's caBIG initiative (NCI Cancer Bulletin, March 22, 2005). Webcast information and a meeting overview are available at http://caBIG.nci.nih.gov/2005_Annual_Meeting.

Science Writers' Seminar on Childhood Cancers
Extraordinary progress has been made in treating childhood cancers. A child diagnosed with cancer in the 1970s had less than a 50 percent chance of surviving for 5 years; today, 5-year survival rates for all childhood cancers are approaching 80 percent. NCI is sponsoring a Science Writers' Seminar to highlight the latest scientific discoveries in children's cancer and treatment on April 26. Speakers will include Drs. Lee Helman and Alan Wayne of NCI; Dr. Donald Small of Johns Hopkins University; and Kathy Russell, acting executive director of the Children's Inn at NIH. An NCI patient will also speak on the experience of having cancer as a child. The seminar will take place from 11 a.m. to 1:30 p.m. in the multipurpose room of the Children's Inn on the NIH campus in Bethesda, Md. Journalists wishing to register for the press briefing should contact Dorie Hightower or Ann Benner in the NCI Press Office at (301) 496-6641 or at ncipressofficers@mail.nih.gov.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov